Clinical Trial Update: Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of biphasic remogliflozin etabonate for type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Remogliflozin Etabonate (remogliflozin etabonate)

Snippet

Sponsor: BHV Pharma | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED